Cargando…
Endothelial-Monocyte Activating Polypeptide II Suppresses the In Vitro Glioblastoma-Induced Angiogenesis by Inducing Autophagy
The obstacle in delivering therapeutics to glioblastoma (GBM) is tumor-induced angiogenesis which leads to the formation of abnormal vessels and a dysfunctional blood-tumor barrier. Here, we elucidated the effect of endothelial-monocyte activating polypeptide II (EMAP II) on the GBM-induced angiogen...
Autores principales: | Li, Zhiqing, Ma, Jun, Liu, Libo, Liu, Xiaobai, Wang, Ping, Liu, Yunhui, Li, Zhen, Zheng, Jian, Chen, Jiajia, Tao, Wei, Xue, Yixue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488748/ https://www.ncbi.nlm.nih.gov/pubmed/28701921 http://dx.doi.org/10.3389/fnmol.2017.00208 |
Ejemplares similares
-
Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells
por: Chen, Jiajia, et al.
Publicado: (2016) -
Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p
por: Zhang, Jian, et al.
Publicado: (2018) -
Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway
por: Zhou, Wei, et al.
Publicado: (2017) -
Autophagy Induction by Endothelial-Monocyte Activating Polypeptide II Contributes to the Inhibition of Malignant Biological Behaviors by the Combination of EMAP II with Rapamycin in Human Glioblastoma
por: Ma, Jun, et al.
Publicado: (2015) -
The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier
por: Liu, Jiahui, et al.
Publicado: (2017)